ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Overview of the most commonly used systems for assessing tumor regression grade (TRG) following neoadjuvant therapy

Overview of the most commonly used systems for assessing tumor regression grade (TRG) following neoadjuvant therapy
Grade Mandard AJCC 2010 Rödel MSKCC
TRG 0 No residual tumor cells No regression
TRG 1 Absence of residual cancer, with fibrosis extending through the various layers of the oesophageal wall (complete regression) Single cells or small groups Fibrosis <25% of tumor mass 100% response
TRG 2 Rare residual cancer cells scattered through the fibrosis Residual cancer with desmoplastic response Fibrosis 25 to 50% of tumor mass 86 to 99% response
TRG 3 An increase in the number of residual cancer cells, but fibrosis still predominates Minimal evidence of tumor response Fibrosis >50% of tumor mass <86% response
TRG 4 Residual cancer outgrowing fibrosis Complete regression
TRG 5 Absence of regressive changes
AJCC: American Joint Committee on Cancer; MSKCC: Memorial Sloan Kettering Cancer Center.
Reprinted with permission from: WHO Classification of Tumours. Digestive System Tumours, 5th ed, Nagtegaal ID, Arends MJ, Odze RD, Lam AK (Eds), Tumours of the colon and rectum, p.183, Copyright © 2019 International Agency for Research on Cancer.
Graphic 122436 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟